BioSpace News Archive

Dry Eye Drugs and Devices Treatment Market: The Thermal Pulsation Devices Segment is Expected to Expand During the Forecast Period

Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca.

October 1, 2021
·
5 min read
Cancer Supportive Care Products Market: Increasing prevalence of cancer across the globe to drive the market

As per the World Cancer Research Fund International, it has been projected that there will be more than 24 million cases of cancer by 2035 globally.

October 1, 2021
·
5 min read
At US$ 8 Bn in 2026, Animal Genetics Market Value will grow by US$ 2.7 Bn Since 2019

Fact.MR – A Market Research and Competitive Intelligence Provider: As per a recent analysis by Fact.MR, the global animal genetics market is poised to total US$ 8 Bn by the end of 2026.

October 1, 2021
·
7 min read
Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray

Quotient Limited, a commercial-stage diagnostics company, announced the launch of the review process of the Expanded Immunohematology technical file dossier for review by the European notified body.

October 1, 2021
·
3 min read
Drug Development

BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced that a scientific abstract titled “Phase 2 Safety and Efficacy Study of Intrathecal MSC-NTF cells in Progressive Multiple Sclerosis” will be presented in an oral presentation at the fully digital 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

October 1, 2021
·
6 min read
Drug Development

Ultimovacs Begins Dosing of Second Cohort in Phase I TENDU Study Investigating Prostate Cancer-Specific Therapeutic Vaccine

Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announced it has started dosing of the second cohort in the Phase I TENDU trial, evaluating the Company’s Tetanus-Epitope Targeting -platform.

October 1, 2021
·
4 min read
Genetown

NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research

NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research

October 1, 2021
·
4 min read
Pharm Country

Bristol Myers Squibb to Hold Investor Event on November 16

Bristol Myers Squibb (NYSE: BMY) today announced that the company will hold an Investor Event in New York City on Tuesday, November 16, 2021 at 9:30 a.m. ET.

October 1, 2021
·
1 min read
Biotech Bay

Latch Bio Emerges from Stealth with Seed Funding Round Led by Lux Capital

Latch Bio today announced the closing of a $5 million seed funding round led by Lux Capital with participation from General Catalyst, Haystack, Fifty Years, and Asimov co-founder and CEO, Alec Nielsen, Ph.D.

October 1, 2021
·
4 min read
Genetown

Agenus to Present AGEN1181 Clinical Data at SITC

Agenus Inc. (NASDAQ: AGEN), today announced acceptance of its abstract describing updated Phase 1 clinical trial results for AGEN1181 (Fc-enhanced anti-CTLA-4) alone and in combination with balstilimab (anti-PD-1) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting.

October 1, 2021
·
2 min read